Medical division star performer at Graseby:
This article was originally published in Clinica
Executive Summary
UK instruments group Graseby reported a 22% increase in sales by the medical division in the first quarter of 1995, boosted by orders from the UK NHS. Order intake grew 20% in the period with the new 9000 series ambulatory infusion pumps accounting for the major proportion. Despite the strong performance of the medical division, Graseby's total first quarter sales were 8% down on last year and group profit was unchanged from the 1994 first quarter.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.